Compare · Fat-loss peptide
Adipotide vs AOD-9604
Both are fat-loss peptide compounds. Here's how they line up on the evidence — graded the same way.
| Adipotide | AOD-9604 | |
|---|---|---|
| Evidence | 3/10 | 7/10 |
| Class | Fat-loss peptide | Fat-loss peptide |
| Summary | A pro-apoptotic peptidomimetic that kills the blood vessels feeding white fat. It produced striking fat loss in obese mice and monkeys, but never cleared safety into meaningful human testing — the lone human trial enrolled four patients and reported no results. | A growth-hormone fragment marketed for fat loss. The human trials were small and short, the pivotal obesity study failed, and development was abandoned. Unapproved as a drug everywhere. |
| Full profile → | Full profile → |
Adipotide
Adipotide (FTPP) has one of the most dramatic ideas behind it of any experimental weight-loss compound. Most diet drugs work on your appetite. This one doesn't. Instead, it's built to cut off the blood supply that feeds white fat. The animal results — in both mice and monkeys — are genuinely…
AOD-9604
AOD-9604 is a lab-made peptide (a small chain of protein building blocks) that was once developed as an anti-obesity drug. Today it's sold widely as a "fat-loss peptide" — but the human studies behind it were small, short, and ended in disappointment.